We are live on ! Find out more
XGN icon

Exagen
XGN

47 hedge funds and large institutions have $46.4M invested in Exagen in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 25 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

9.92% more ownership

Funds ownership: 56.01% → 65.93% (+9.9%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

11% less funds holding

Funds holding: 53 → 47 (-6)

36% less capital invested

Capital invested by funds: $73M → $46.4M (-$26.6M)

38% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 13

60% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 25

Holders
47
Holders Change
-6
Holders Change %
-11.32%
% of All Funds
0.79%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
8
Increased
10
Reduced
25
Closed
13
Calls
$1.54M
Puts
–
Net Calls
+$1.54M
Net Calls Change
-$313K

Top Buyers

Rank Fund Capital Flow
1
HT
HighTower Trust
Texas
+$15.6M
2
SCM
Stonepine Capital Management
Oregon
+$811K
3
Millennium Management
Millennium Management
New York
+$464K
4
E
Ergoteles
New York
+$292K
5
PCM
Perkins Capital Management
Minnesota
+$210K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$2.9M
2
CCPM
Cooper Creek Partners Management
New York
-$1.23M
3
N
Natixis
France
-$1M
4
CPA
Cowen Prime Advisors
New York
-$576K
5
State Street
State Street
Massachusetts
-$572K
Name Holding Trade Value Shares
Change 		Change in
Stake
CAC
1
Cowen and Company
New York
$7.78M -$170K -29,217 -2%
SCM
2
Stonepine Capital Management
Oregon
$7.24M +$811K +139,347 +12%
RI
3
RTW Investments
New York
$5.88M +$203K +34,859 +4%
WA
4
Wasatch Advisors
Utah
$5.81M -$450K -77,367 -7%
Morgan Stanley
5
Morgan Stanley
New York
$2.86M -$208K -35,705 -7%
SAM
6
Silvercrest Asset Management
New York
$2.85M -$128K -22,029 -4%
Vanguard Group
7
Vanguard Group
Pennsylvania
$2.82M -$270K -46,360 -9%
PIM
8
Platinum Investment Management
Australia
$2.3M – – –
PCM
9
Perkins Capital Management
Minnesota
$1.36M +$210K +36,000 +18%
NCM
10
Nantahala Capital Management
Connecticut
$896K -$18.2K -3,118 -2%
UBS Group
11
UBS Group
Switzerland
$756K -$1.74K -298 -0.2%
BCI
12
Brinker Capital Investments
Pennsylvania
$520K -$15.3K -2,622 -3%
PM
13
Penbrook Management
New York
$506K -$2.91K -500 -0.6%
PCMI
14
Paradigm Capital Management Inc
New York
$466K +$141K +24,289 +43%
Millennium Management
15
Millennium Management
New York
$457K +$464K +79,629 New
Geode Capital Management
16
Geode Capital Management
Massachusetts
$431K -$456K -78,333 -51%
BlackRock
17
BlackRock
New York
$425K -$2.9M -497,322 -87%
Deutsche Bank
18
Deutsche Bank
Germany
$421K -$32.7K -5,609 -7%
Dimensional Fund Advisors
19
Dimensional Fund Advisors
Texas
$395K -$18.9K -3,238 -4%
E
20
Ergoteles
New York
$288K +$292K +50,100 New
BCM
21
Bridgeway Capital Management
Texas
$272K -$161K -27,700 -37%
ACM
22
Advisors Capital Management
New Jersey
$235K +$6.43K +1,104 +3%
HT
23
HighTower Trust
Texas
$231K +$15.6M +2,683,578 New
State Street
24
State Street
Massachusetts
$193K -$572K -98,332 -74%
Citadel Advisors
25
Citadel Advisors
Florida
$160K +$163K +27,996 New
1
2 3

XGN Hedge Fund Activity: Q2 2022 in Review

47 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Exagen (XGN) for Q2 2022, worth a combined $46.4M — down 36% from $73M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of XGN and 8 opened new positions — a net loss of 5 holders — while 25 trimmed existing stakes and 10 added.

The largest buyer was HighTower Trust, opening a new position worth an estimated $15.6M. The largest seller was BlackRock, cutting an estimated $2.9M.

  • 47 institutional investors held Exagen (XGN) as of Q2 2022, down from 53 in Q1 2022.
  • Funds reported $46.4M of Exagen stock for Q2 2022, down 36% quarter-over-quarter.
  • 8 funds opened new Exagen positions in Q2 2022 and 13 closed out, a net change of -5 holders.
  • The largest Exagen buyer in Q2 2022 was HighTower Trust, an estimated $15.6M added.
  • The largest Exagen seller in Q2 2022 was BlackRock, an estimated $2.9M sold.

Based on aggregated 13F filings for Q2 2022.